Clinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line Sunitinib

Condition:   Metastatic Renal Cell Carcinoma Intervention:   Drug: Sunitinib Sponsors:   Pfizer;   International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials